The authors regret that the world map presented in Figure 1 was incomplete. Please see the correct image for Fig 1 below. This has also been updated in the online article.
The authors would like to apologise for any inconvenience caused.
. 2021 Oct 21;160:289–290. doi: 10.1016/j.ejca.2021.10.001
Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]
Nicola Fazio
a,∗, Lorenzo Gervaso
a,b, Thorvardur R Halfdanarson
c, Anna La Salvia
d, Johannes Hofland
e, Jorge Hernando
f, Mohamad B Sonbol
g, Rocio Garcia-Carbonero
d, Jaume Capdevila
f, Wouter W de Herder
e, Anna Koumarianou
h, Gregory Kaltsas
i, Maura Rossi
j, Simona Grozinsky-Glasberg
k, Kira Oleinikov
k, Sabrina Boselli
l, Darina Tamayo
l, Vincenzo Bagnardi
m, Alice Laffi
a, Manila Rubino
a, Francesca Spada
a
Nicola Fazio
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Nicola Fazio
Lorenzo Gervaso
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
bMolecular Medicine Program, University of Pavia, Pavia, Italy
Find articles by Lorenzo Gervaso
Thorvardur R Halfdanarson
cDivision of Medical Oncology Mayo Clinic, Rochester, MN, USA
Find articles by Thorvardur R Halfdanarson
Anna La Salvia
dMedical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain
Find articles by Anna La Salvia
Johannes Hofland
eDepartment of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands
Find articles by Johannes Hofland
Jorge Hernando
fVall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain
Find articles by Jorge Hernando
Mohamad B Sonbol
gDepartment of Hematology and Oncology Mayo Clinic, Phoenix, AZ, USA
Find articles by Mohamad B Sonbol
Rocio Garcia-Carbonero
dMedical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain
Find articles by Rocio Garcia-Carbonero
Jaume Capdevila
fVall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain
Find articles by Jaume Capdevila
Wouter W de Herder
eDepartment of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands
Find articles by Wouter W de Herder
Anna Koumarianou
hHematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Find articles by Anna Koumarianou
Gregory Kaltsas
i1st Department of Propaedeutic Internal Medicine, Endocrine Unit, National and Kapodistrian, University of Athens, Athens, 11527, Greece
Find articles by Gregory Kaltsas
Maura Rossi
jOncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Find articles by Maura Rossi
Simona Grozinsky-Glasberg
kNeuroendocrine Tumors Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Find articles by Simona Grozinsky-Glasberg
Kira Oleinikov
kNeuroendocrine Tumors Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Find articles by Kira Oleinikov
Sabrina Boselli
lData Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Sabrina Boselli
Darina Tamayo
lData Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Darina Tamayo
Vincenzo Bagnardi
mDepartment of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy
Find articles by Vincenzo Bagnardi
Alice Laffi
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Alice Laffi
Manila Rubino
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Manila Rubino
Francesca Spada
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Find articles by Francesca Spada
aDivision of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
bMolecular Medicine Program, University of Pavia, Pavia, Italy
cDivision of Medical Oncology Mayo Clinic, Rochester, MN, USA
dMedical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain
eDepartment of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands
fVall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain
gDepartment of Hematology and Oncology Mayo Clinic, Phoenix, AZ, USA
hHematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
i1st Department of Propaedeutic Internal Medicine, Endocrine Unit, National and Kapodistrian, University of Athens, Athens, 11527, Greece
jOncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
kNeuroendocrine Tumors Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
lData Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
mDepartment of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy
∗
Corresponding author: Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Via G. Ripamonti 435, Milan, 20141, Italy.
Issue date 2022 Jan.
© 2021 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8529581 PMID: 34690038
This corrects the article "Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study" in volume 154 on page 246.